Deep nasal sinus cavity microbiota dysbiosis in Parkinson's diseaseOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This proof-of-concept study examined the microbiota of the deep nasal sinus cavity in Parkinson's disease. This site sits near the olfactory bulb, a proposed trigger of neuroinflammation. Rhinologists collected endoscopy-guided swabs from the middle meatus. Samples were profiled with 16S rRNA gene sequencing, using both a multi-amplicon panel and a standard V4 approach, and compared against clinical scores.
Who was studied?
The cross-sectional case-control study enrolled 58 participants at Rush University Medical Center in Chicago. These included 30 Parkinson's patients and 28 healthy controls. Controls comprised 17 random non-household subjects and 11 spouses living with patients. Patients were Hoehn and Yahr stage 1 to 3, matched to controls by age and sex, and assessed for motor severity and smell.
What were the most important findings?
Parkinson's patients had a distinct deep nasal microbiota with lower species richness than random controls. Putative pro-inflammatory species were enriched, including Moraxella catarrhalis, whose relative abundance ranged widely and reached 91.46% in some patients. Moraxella catarrhalis correlated with more severe motor scores. Anti-inflammatory, short-chain-fatty-acid-producing bacteria were reduced. Patient microbiomes resembled those of their spouses more than non-household controls, and Proteobacteria abundance tracked motor complication scores.
What are the greatest implications of this study?
The findings suggest a pro-inflammatory nasal community near the olfactory bulb could contribute to Parkinson's neuroinflammation. This supports the hypothesis that the olfactory route participates in disease. The small sample and cross-sectional design cannot establish causation. Spousal similarity implies shared environment shapes some changes, so household controls are valuable for future Parkinson's microbiome studies.